HPV screening for cervical cancer in rural India.

By J. Ankit, Jain Prakriti, K. Lakshmaiah. New England Journal of Medicine, 2009

785 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/5f251108ddcc8257527dc87846be1723460ad203

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. R. Siegel
2. Lindsey A. Torre
3. A. Jemal
4. F. Bray
5. J. Ferlay
6. X. Castellsagué
7. Elizabeth E. Ward
8. N. Muñoz

Citations in the corpus

• Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. (2010, background): “This discovery has led to great advances in the prevention of this disease on two fronts: 1) primary prevention by the use of prophylactic HPV vaccines (4–10) and 2) prevention by increasing the efficacy of cervical cancer screening (11).”
• Global cancer statistics (2011, background): “A recent clinical trial in rural India, a low-resource area, found that a single round of HPV DNA testing was associated with about a 50% reduction in the risk of developing advanced cervical cancer and associated deaths.(92)”
• Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. (2010, background): “HPV vaccines are being widely introduced in Western countries [1, 2], promising new broad-spectrum HPV vaccines are in development [3, 4], and the use of novel strategies based on the use of HPV DNA assays as primary cervical screening is increasingly recommended [5, 6].”
• Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2017, background): “However, cervical cancer still represents a major public health problem even in developed countries: 54 517 new cases of invasive cervical cancer are diagnosed in Europe every year and 24 874 women die of this disease [4].”
• Global cancer statistics, 2012 (2015, background): “A clinical trial in rural India found that a single round of HPV testing reduced the number of cervical cancer deaths by about 50%.(98)”
• Worldwide burden of cervical cancer in 2008. (2011, background): “Another landmark finding was the demonstration, in a large randomised study conducted in India, that screening with a high-risk HPV DNA assay once in a lifetime results in a reduction of the incidence of advanced cervical cancer as well as the cause-specific mortality by about one-half [44].”